Literature DB >> 15542884

The million women study: a critique.

Malcolm Whitehead1, Richard Farmer.   

Abstract

The regulatory authority in the UK, the Committee on Safety of Medicines, issued advice to health professionals on the day the results of the Million Women Study (MWS) were published. This course of action was undertaken before review of the study by the international medical and scientific community. We have reviewed the methodology of the MWS. It is our belief that the flaws in the design render the results largely uninterpretable because built in biases have affected risk estimates.

Entities:  

Mesh：

Year:  2004        PMID： 15542884     DOI： 10.1385/ENDO:24:3:187

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.925


  29 in total

1.  Breast cancer and hormone-replacement therapy: the Million Women Study.

Authors:  Mark Garton
Journal:  Lancet       Date:  2003-10-18       Impact factor: 79.321

2.  Breast cancer and hormone-replacement therapy: the Million Women Study.

Authors:  N J Bundred; Julie Morris
Journal:  Lancet       Date:  2003-10-18       Impact factor: 79.321

3.  Breast cancer and hormone-replacement therapy: the Million Women Study.

Authors:  Judith M Bliss; Richard Gray
Journal:  Lancet       Date:  2003-10-18       Impact factor: 79.321

Review 4.  The Million Women Study and breast cancer.

Authors:  Leon Speroff
Journal:  Maturitas       Date:  2003-09-25       Impact factor: 4.342

5.  The Million Women Study, an additional observational study with the implications and limits of an observational study.

Authors:  Wilhelm Braendle
Journal:  Maturitas       Date:  2003-10-20       Impact factor: 4.342

6.  THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION?

Authors:  A B HILL
Journal:  Proc R Soc Med       Date:  1965-05

7.  The risk of breast cancer after estrogen and estrogen-progestin replacement.

Authors:  L Bergkvist; H O Adami; I Persson; R Hoover; C Schairer
Journal:  N Engl J Med       Date:  1989-08-03       Impact factor: 91.245

8.  Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.

Authors: 
Journal:  Lancet       Date:  1997-10-11       Impact factor: 79.321

9.  Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.

Authors:  Garnet L Anderson; Marian Limacher; Annlouise R Assaf; Tamsen Bassford; Shirley A A Beresford; Henry Black; Denise Bonds; Robert Brunner; Robert Brzyski; Bette Caan; Rowan Chlebowski; David Curb; Margery Gass; Jennifer Hays; Gerardo Heiss; Susan Hendrix; Barbara V Howard; Judith Hsia; Allan Hubbell; Rebecca Jackson; Karen C Johnson; Howard Judd; Jane Morley Kotchen; Lewis Kuller; Andrea Z LaCroix; Dorothy Lane; Robert D Langer; Norman Lasser; Cora E Lewis; JoAnn Manson; Karen Margolis; Judith Ockene; Mary Jo O'Sullivan; Lawrence Phillips; Ross L Prentice; Cheryl Ritenbaugh; John Robbins; Jacques E Rossouw; Gloria Sarto; Marcia L Stefanick; Linda Van Horn; Jean Wactawski-Wende; Robert Wallace; Sylvia Wassertheil-Smoller
Journal:  JAMA       Date:  2004-04-14       Impact factor: 56.272

10.  Why the Million Women Study is important for European women.

Authors:  Martina Dören
Journal:  Maturitas       Date:  2003-10-20       Impact factor: 4.342
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.